LIGAND PHARMACEUTICAL INC (LGNXZ)
USD 0.0
(18.18%)
USD 0.0
(18.18%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -16.78 Million USD | -139.28% |
| 2022 | 42.74 Million USD | -85.98% |
| 2021 | 304.86 Million USD | -25.36% |
| 2020 | 408.45 Million USD | -29.32% |
| 2019 | 577.89 Million USD | 11.88% |
| 2018 | 516.51 Million USD | 131.86% |
| 2017 | 222.76 Million USD | -0.43% |
| 2016 | 223.72 Million USD | 55.16% |
| 2015 | 144.18 Million USD | 237.54% |
| 2014 | 42.71 Million USD | 842.0% |
| 2013 | -5.75 Million USD | -70.38% |
| 2012 | -3.37 Million USD | -354.83% |
| 2011 | 1.32 Million USD | -82.94% |
| 2010 | 7.77 Million USD | 148.48% |
| 2009 | -16.03 Million USD | 39.67% |
| 2008 | -26.57 Million USD | 65.12% |
| 2007 | -76.18 Million USD | 35.71% |
| 2006 | -118.49 Million USD | -214.2% |
| 2005 | 103.76 Million USD | 31.18% |
| 2004 | 79.1 Million USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 58.74 Million USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -10.55 Million USD | 75.95% |
| 2024 Q1 | -43.89 Million USD | -161.47% |
| 2023 Q2 | -16.77 Million USD | -32157.69% |
| 2023 Q1 | -52 Thousand USD | -100.12% |
| 2023 Q3 | -12.94 Million USD | 22.82% |
| 2023 Q4 | -16.78 Million USD | -29.68% |
| 2023 FY | -16.78 Million USD | -139.28% |
| 2022 Q1 | 180.2 Million USD | -43.47% |
| 2022 FY | 42.74 Million USD | -85.98% |
| 2022 Q2 | 139.33 Million USD | -22.68% |
| 2022 Q4 | 42.74 Million USD | -61.06% |
| 2022 Q3 | 109.77 Million USD | -21.22% |
| 2021 Q2 | 300.4 Million USD | -10.01% |
| 2021 Q1 | 333.8 Million USD | 829.89% |
| 2021 FY | 304.86 Million USD | -25.36% |
| 2021 Q4 | 318.78 Million USD | 3.79% |
| 2021 Q3 | 307.15 Million USD | 2.25% |
| 2020 Q4 | -45.73 Million USD | -2413.3% |
| 2020 Q1 | 336.13 Million USD | -41.78% |
| 2020 Q2 | 343.69 Million USD | 2.25% |
| 2020 Q3 | 1.97 Million USD | -99.42% |
| 2020 FY | 408.45 Million USD | -29.32% |
| 2019 Q1 | 538.63 Million USD | 3.76% |
| 2019 Q4 | 577.38 Million USD | 38.74% |
| 2019 Q3 | 416.16 Million USD | 7.05% |
| 2019 FY | 577.89 Million USD | 11.88% |
| 2019 Q2 | 388.73 Million USD | -27.83% |
| 2018 Q4 | 519.13 Million USD | -25.88% |
| 2018 Q2 | 654.82 Million USD | 239.99% |
| 2018 Q1 | 192.6 Million USD | -13.54% |
| 2018 Q3 | 700.42 Million USD | 6.96% |
| 2018 FY | 516.51 Million USD | 131.86% |
| 2017 Q2 | 182.7 Million USD | -21.27% |
| 2017 FY | 222.76 Million USD | -0.43% |
| 2017 Q4 | 222.76 Million USD | 5.87% |
| 2017 Q3 | 210.41 Million USD | 15.17% |
| 2017 Q1 | 232.05 Million USD | 3.73% |
| 2016 Q3 | 155.67 Million USD | -13.96% |
| 2016 FY | 223.72 Million USD | 55.16% |
| 2016 Q4 | 223.72 Million USD | 43.71% |
| 2016 Q2 | 180.92 Million USD | 4.02% |
| 2016 Q1 | 173.93 Million USD | 59.75% |
| 2015 Q2 | -103.4 Million USD | 35.38% |
| 2015 Q1 | -160.01 Million USD | -506.86% |
| 2015 FY | 144.18 Million USD | 237.54% |
| 2015 Q4 | 108.87 Million USD | 221.35% |
| 2015 Q3 | -89.72 Million USD | 13.23% |
| 2014 Q3 | -173.4 Million USD | -1589.95% |
| 2014 Q2 | -10.26 Million USD | -30.15% |
| 2014 Q1 | -7.88 Million USD | -36.95% |
| 2014 FY | 42.71 Million USD | 842.0% |
| 2014 Q4 | 39.32 Million USD | 122.68% |
| 2013 FY | -5.75 Million USD | -70.38% |
| 2013 Q2 | 1.29 Million USD | -57.67% |
| 2013 Q3 | 3.31 Million USD | 156.5% |
| 2013 Q1 | 3.05 Million USD | 190.32% |
| 2013 Q4 | -5.75 Million USD | -273.72% |
| 2012 Q1 | 1.09 Million USD | -17.12% |
| 2012 FY | -3.37 Million USD | -354.83% |
| 2012 Q2 | 1.52 Million USD | 38.67% |
| 2012 Q3 | 2.47 Million USD | 62.4% |
| 2012 Q4 | -3.37 Million USD | -236.53% |
| 2011 Q3 | 6.92 Million USD | 7.79% |
| 2011 Q1 | 4.51 Million USD | -41.91% |
| 2011 Q2 | 6.42 Million USD | 42.19% |
| 2011 Q4 | 1.32 Million USD | -80.84% |
| 2011 FY | 1.32 Million USD | -82.94% |
| 2010 Q1 | -4.04 Million USD | 74.78% |
| 2010 Q2 | -3.23 Million USD | 20.0% |
| 2010 Q3 | -3.79 Million USD | -17.34% |
| 2010 FY | 7.77 Million USD | 148.48% |
| 2010 Q4 | 7.77 Million USD | 304.74% |
| 2009 FY | -16.03 Million USD | 39.67% |
| 2009 Q4 | -16.03 Million USD | -210.7% |
| 2009 Q3 | -5.16 Million USD | -46.42% |
| 2009 Q2 | -3.52 Million USD | 27.58% |
| 2009 Q1 | -4.86 Million USD | 81.69% |
| 2008 Q4 | -26.57 Million USD | -128.52% |
| 2008 Q3 | -11.62 Million USD | 59.78% |
| 2008 Q2 | -28.91 Million USD | 51.11% |
| 2008 Q1 | -59.14 Million USD | 22.37% |
| 2008 FY | -26.57 Million USD | 65.12% |
| 2007 Q2 | -102.35 Million USD | 74.56% |
| 2007 Q3 | -68.41 Million USD | 33.16% |
| 2007 Q4 | -76.18 Million USD | -11.36% |
| 2007 Q1 | -402.27 Million USD | -239.48% |
| 2007 FY | -76.18 Million USD | 35.71% |
| 2006 Q2 | 101.05 Million USD | 7.11% |
| 2006 Q4 | -118.49 Million USD | -189.5% |
| 2006 FY | -118.49 Million USD | -214.2% |
| 2006 Q3 | 132.4 Million USD | 31.02% |
| 2006 Q1 | 94.34 Million USD | -9.08% |
| 2005 Q3 | 120.94 Million USD | -12.73% |
| 2005 Q4 | 103.76 Million USD | -14.21% |
| 2005 FY | 103.76 Million USD | 31.18% |
| 2005 Q1 | 120.48 Million USD | 52.31% |
| 2005 Q2 | 138.58 Million USD | 15.02% |
| 2004 Q2 | 129.18 Million USD | 22.35% |
| 2004 Q1 | 105.59 Million USD | 278.88% |
| 2004 Q4 | 79.1 Million USD | 0.0% |
| 2004 FY | 79.1 Million USD | 0.0% |
| 2003 Q4 | -59.03 Million USD | -169.5% |
| 2003 Q1 | 145.97 Million USD | 31.22% |
| 2003 Q2 | 134.4 Million USD | -7.93% |
| 2003 FY | - USD | -100.0% |
| 2003 Q3 | 84.93 Million USD | -36.81% |
| 2002 Q2 | - USD | 0.0% |
| 2002 FY | 58.74 Million USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q3 | -19.44 Million USD | 0.0% |
| 2002 Q4 | 111.24 Million USD | 672.11% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 415.78 Thousand USD | 4137.875% |
| Allstar Health Brands, Inc. | 2.21 Million USD | 859.661% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | -111.13 Million USD | 84.892% |
| Café Serendipity Holdings, Inc. | 409.94 Thousand USD | 4195.457% |
| Decision Diagnostics Corp. | - USD | Infinity% |
| Health Advance Inc. | 271.74 Thousand USD | 6278.332% |
| HealthWarehouse.com, Inc. | 2.17 Million USD | 872.989% |
| MedGen, Inc. | 24.36 USD | 68920461.248% |
| Omni Health, Inc. | 1.46 Million USD | 1248.391% |
| Oxford Investments Holdings Inc. | 172.66 Thousand USD | 9823.284% |
| Pineapple, Inc. | 8.1 Million USD | 307.03% |
| ScripsAmerica, Inc. | 748.59 Thousand USD | 2342.744% |